Advisory Committee on Immunization Practices (ACIP), 27392 [2013-11112]
Download as PDF
<![CDATA[
27392
Federal Register / Vol. 78, No. 91 / Friday, May 10, 2013 / Notices
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–11188 Filed 5–9–13; 8:45 am]
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–11112 Filed 5–9–13; 8:45 am]
BILLING CODE 4160–18–P
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
Times and Dates: 8:00 a.m.–5:00 p.m., June
19, 2013; 8:00 a.m.–4:00 p.m., June 20, 2013.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines. Further, under
provisions of the Affordable Care Act, at
section 2713 of the Public Health Service
Act, immunization recommendations of the
ACIP that have been adopted by the Director
of the Centers for Disease Control and
Prevention must be covered by applicable
health plans.
Matters To Be Discussed: The agenda will
include discussions on: General
recommendations, influenza, Japanese
encephalitis vaccine, pertussis vaccine,
Herpes zoster vaccine, rotavirus vaccines,
human papillomavirus vaccines, and vaccine
supply. Recommendation votes are
scheduled for influenza and Japanese
encephalitis vaccine. Time will be available
for public comment. Agenda items are
subject to change as priorities dictate.
Contact Person for More Information:
Felicia Betancourt, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30333, Telephone: (404)
639–8836, Email: ACIP@CDC.GOV
The meeting is webcast live via the World
Wide Web; for instructions and more
information on ACIP please visit the ACIP
Web site: https://www.cdc.gov/vaccines/acip/
index.html.
The Director, Management Analysis and
Services Office, has been delegated the
VerDate Mar<15>2010
18:05 May 09, 2013
Jkt 229001
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 25743–25746,
dated May 2, 2013) is amended to
establish the Office of Safety, Security,
and Asset Management, Office of the
Chief Operating Officer, Office of the
Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the titles and
functional statements for the Buildings
and Facilities Office (CAJC); the
Logistics Management Branch (CAJHW),
Procurement and Grants Office (CAJH);
the Office of Security and Emergency
Preparedness (CAJJ); Office of Safety,
Health and Environment (CAJP); insert
the following:
Office of Safety, Security and Asset
Management (CAJS). The Office of
Safety, Security and Asset Management
(OSSAM) serves as the lead
organizational entity for providing a
safe, secure, functional, and healthy
workplace environment for Centers for
Disease Control and Prevention (CDC)
staff while ensuring environmental
stewardship and appropriate
management of agency assets.
Office of the Director (CAJS1). (1)
Directs, manages, coordinates and
evaluates the programs and activities of
OSSAM service offices; (2) develops
goals and objectives and provides
leadership, policy formulation and
guidance in program planning and
development; and (3) provides advice
and counsel to the CDC Director, the
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Chief Operating Officer, and other
senior Office of the Director (OD) and
Centers/Institute/Offices (CIO) officials
on all OSSAM programs and activities.
Office of Financial, Administrative,
and Information Services (CJAS12). (1)
Provides administrative guidance,
advice, and support to OSSAM
employees; (2) manages OSSAM
information technology support,
including system development,
maintenance, design and
implementation; (3) provides direction,
strategy, analysis, and operational
support in all aspects of OSSAM’s
human resources operations; (4)
develops and implements internal
policies and procedures, including
developing related communications; (5)
serves as the performance ombudsman
for OS SAM; (6) provides office space
allocation for all OSSAM programs; (7)
serves as the point of contact between
OSSAM OD and the Office of the Chief
Financial Officer; (8) provides funding
ceiling information to each OSSAM
office; (9) manages all OSSAM salary
and budget spending; (10) provides
oversight, guidance and approval for the
procurement process OS SAM-wide;
(11) provides oversight of property
accountability, including appointing an
OSSAM property accountability officer;
(12) provides guidance and oversight
related to the records management
requirements and process; and (13)
establishes and enforces OSSAM-related
travel policies.
Office of Operations (CAJS13). (1)
Implements, maintains, and updates
CDC’s Integrated Emergency
Management Program, Emergency
Response Plans (ERPs) and CDC
Continuity Of Operations (COOP)
communications vehicles; (2) conducts
and evaluates annual tabletop,
functional, and full-scale exercises for
all CDC facilities with ERPs; (3)
recommends future emergency
management and emergency responserelated programs, policies, and/or
procedures; (4) oversees technical
programs to ensure a safe, secure and
healthy workplace while ensuring all
worksite issues are properly addressed
and brought to closure; (5) oversees the
Quarterly Performance Review process;
and (6) provides oversight and guidance
to OSSAM liaison officers who support
programs as the key contact for matters
related to safety, security, facilities,
logistics and sustainability.
Public Health and Intelligence Office
(CAJS14). (1) Provides leadership and
operational and technical support for
development and implementation of
intelligence activities; (2) analyzes and
disseminates intelligence related to
public health, medical and scientific
E:\FR\FM\10MYN1.SGM
10MYN1
]]>Agencies
[Federal Register Volume 78, Number 91 (Friday, May 10, 2013)]
[Notices]
[Page 27392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-11112]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates: 8:00 a.m.-5:00 p.m., June 19, 2013; 8:00 a.m.-
4:00 p.m., June 20, 2013.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines. Further, under provisions of the Affordable Care Act,
at section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been adopted by the Director
of the Centers for Disease Control and Prevention must be covered by
applicable health plans.
Matters To Be Discussed: The agenda will include discussions on:
General recommendations, influenza, Japanese encephalitis vaccine,
pertussis vaccine, Herpes zoster vaccine, rotavirus vaccines, human
papillomavirus vaccines, and vaccine supply. Recommendation votes
are scheduled for influenza and Japanese encephalitis vaccine. Time
will be available for public comment. Agenda items are subject to
change as priorities dictate.
Contact Person for More Information: Felicia Betancourt,
National Center for Immunization and Respiratory Diseases, CDC, 1600
Clifton Road NE., MS-A27, Atlanta, Georgia 30333, Telephone: (404)
639-8836, Email: ACIP@CDC.GOV
The meeting is webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: https://www.cdc.gov/vaccines/acip/.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-11112 Filed 5-9-13; 8:45 am]
BILLING CODE 4160-18-P
